Patients with uncontrolled severe hypertension.
Those allergic to the drug or other erythropoietin preparations.
Those with concurrent infection, who shall use the drug after the infection is under control.
Patient who develop Pure Red Cell Aplasia (PRCA) following treatment with any erythropoietin should not receive Epoetinum alfa or any other erythropoietin should not receive Epoetinum alfa or any other erythropoietin (see Pure Red Cell Aplasia under Precautions).